<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Scientifica (Cairo)</journal-id><journal-id journal-id-type="iso-abbrev">Scientifica (Cairo)</journal-id><journal-id journal-id-type="publisher-id">SCIENTIFICA</journal-id><journal-title-group><journal-title>Scientifica</journal-title></journal-title-group><issn pub-type="epub">2090-908X</issn><publisher><publisher-name>Hindawi</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7704184</article-id><article-id pub-id-type="doi">10.1155/2020/8637583</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>Medicinal Plants as a Drug Alternative Source for the Antigout Therapy in Morocco</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-3516-318X</contrib-id><name><surname>Daoudi</surname><given-names>Nour Elhouda</given-names></name><xref ref-type="aff" rid="I1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-9944-811X</contrib-id><name><surname>Bouhrim</surname><given-names>Mohamed</given-names></name><xref ref-type="aff" rid="I1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-2839-4059</contrib-id><name><surname>Ouassou</surname><given-names>Hayat</given-names></name><xref ref-type="aff" rid="I1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-9473-1290</contrib-id><name><surname>Bnouham</surname><given-names>Mohamed</given-names></name><email>mbnouham@yahoo.fr</email><xref ref-type="aff" rid="I1"/></contrib></contrib-group><aff id="I1"> Laboratory of Bioresources Biotechnology Ethnopharmacology and Health, Department of Biology, Faculty of Sciences, University Mohamed I, Oujda, Morocco</aff><author-notes><fn fn-type="other"><p>Academic Editor: Abdel Halim Salem</p></fn></author-notes><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>23</day><month>11</month><year>2020</year></pub-date><volume>2020</volume><elocation-id>8637583</elocation-id><history><date date-type="received"><day>14</day><month>7</month><year>2020</year></date><date date-type="rev-recd"><day>4</day><month>11</month><year>2020</year></date><date date-type="accepted"><day>10</day><month>11</month><year>2020</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2020 Nour Elhouda Daoudi et al.</copyright-statement><copyright-year>2020</copyright-year><license xlink:href="https://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec><title>Background</title><p> The gout is a metabolic disease that is associated with a high level of uric acid in the blood. This disease is treated with some medications that aim to reduce serum urate levels. However, the use of various medicines leads to the appearance of some side effects, hence the importance of using other treatments based on natural resources. </p></sec><sec><title>Objective</title><p> This study presents some medical treatments, their side effects, and some plants that are used for gout management in Morocco in the aim to valorize them. </p></sec><sec><title>Methods</title><p> We have been consulting various English publications in PubMed, Web of Science, and ScienceDirect published between 1991 and 2019 using the following keywords &#x0201c;drugs,&#x0201d; &#x0201c;gout,&#x0201d; &#x0201c;Morocco,&#x0201d; &#x0201c;medicinal plants,&#x0201d; &#x0201c;<italic>in vitro</italic>,&#x0201d; and &#x0201c;<italic>in vivo</italic>&#x0201d; terms. Then, we have classified the medicines, according to their action mechanisms, and we have cited some species that were reported in Moroccan pharmacopeia as antigout. </p></sec><sec><title>Results</title><p> Three methods of the gout medical management were cited in this work: xanthine oxidase inhibitors, uric acid excretion enhancer, and uricase recombinant. However, it was found that these treatments had various side effects. We have described 23 species, and some of them showed experimentally an antigout effect by blocking the &#x0201c;xanthine oxidase&#x0201d; enzyme. These plants belong to 11 families. Lamiaceae represents the most dominant family with six species followed by Asteraceae with two species. Colchicine isolated from <italic>Colchicum autumnale</italic> is the most known compound for its efficiency towards gout. </p></sec><sec><title>Conclusion</title><p> This work summarized different treatments particularly medicinal plants that are used in Morocco to treat gout disease by blocking uric acid secretion. However, several studies are needed to valorize these antigout natural sources.</p></sec></abstract></article-meta></front><body><sec id="sec1"><title>1. Introduction</title><p>Gout is a chronic disorder, which is known also as &#x0201c;a disease of kings.&#x0201d; Sir Alfred Baring Garrod discovered it in 1848 [<xref rid="B1" ref-type="bibr">1</xref>]. This disease is characterized by the deposition of urate crystal in several tissues [<xref rid="B2" ref-type="bibr">2</xref>]. It affects many joints, particularly the first metatarsophalangeal joint of the foot. Additionally, it attacks the arms, knees, and ankles [<xref rid="B3" ref-type="bibr">3</xref>]. Mostly, this disease is associated with many risk factors as hyperuricemia, genetic factors, metabolism syndrome, dietary factors, alcohol consumption, osteoarthritis, kidney failure, diuretic, and some medication uses [<xref rid="B4" ref-type="bibr">4</xref>].</p><p>The most frequent inflammatory arthritis in the world is gout. It is characterized by prevalence higher than 1% in the occidental countries, especially in Europe and North America [<xref rid="B1" ref-type="bibr">1</xref>]. Actually, recent works suggest that men have a higher prevalence and incidence of gout than women [<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B4" ref-type="bibr">4</xref>]. Indeed, it is necessary to take this disease seriously because it is associated with various health complications as cardiovascular risk, hypertension, chronic kidney disorder, obesity, and metabolic syndrome [<xref rid="B5" ref-type="bibr">5</xref>&#x02013;<xref rid="B7" ref-type="bibr">7</xref>].</p><p>The main cause of hyperuricemia is the unbalance between the production and excretion rate of uric acid. Purines principally degraded by a hepatic enzyme named xanthine oxidase are involved in the appearance of hyperuricemia. A high-purine diet that leads to purine metabolism raise, excessive alcohol consumption, and tumor lysis syndrome associated with the alteration of a large number of cells, contributing to the increased uric acid production. Indeed, a reduction in excretion and rising reabsorption of uric acid causes hyperuricemia. Furthermore, uric acid transporters are required in uric acid renal handling which consists of tubular reabsorption/secretion and glomerular filtration. In fact, reabsorption-related proteins include generally glucose transporter 9 (GLUT9), organic anion transporter 4 (OAT4), and urate anion transporter 1 (URAT1). However, secretion-related transporters include OAT1, OAT3, multidrug resistance protein 4 (MRP4/ABCC4), and breast cancer resistance protein (BCRP/ABCG2) [<xref rid="B8" ref-type="bibr">8</xref>] (<xref ref-type="fig" rid="fig1">Figure 1</xref>).</p><p>Generally, gout is treated with some medications to lower the level of the serum urate by the inhibition of the xanthine oxidase in the liver. Among those treatments, we have febuxostat and allopurinol [<xref rid="B9" ref-type="bibr">9</xref>]. Colchicine extracted by <italic>Colchicum autumnale</italic> is another kind of gout therapy [<xref rid="B10" ref-type="bibr">10</xref>]. Unfortunately, these drugs have various side effects. For example, allopurinol causes nephrolithiasis, renal toxicity, liver necrosis, and allergic reactions [<xref rid="B11" ref-type="bibr">11</xref>]. For these, people seek better alternatives based on the use of medicinal plants because of their availability, easy accessibility, and people believe that natural products are not harmful [<xref rid="B12" ref-type="bibr">12</xref>]. Morocco is characterized by flora diversity, and it contains 4200 species in which 800 are considered therapeutic herbs [<xref rid="B13" ref-type="bibr">13</xref>]. The medicinal plants of this country have been used traditionally to treat several complications as gout. In fact, several plants were reported in pharmacopeia as antigout products, and most of them have shown experimentally this activity. Although, these plants remain underexploited and require other studies in order to confirm this effect and to identify different molecules responsible for this beneficial effect. Therefore, in this review, we have summarized information about medical treatment and plants that are used for gout management in Morocco with the aim to valorize the Moroccan bioresources. For this reason, we have been consulting various English publications in PubMed, Web of Science, and ScienceDirect databases, published between 1991 and 2019.</p></sec><sec id="sec2"><title>2. Medical Treatment</title><p>The principle of gout management is based on reducing and maintaining the serum urate at the normal value (&#x0003c;6.0&#x02009;mg/d) [<xref rid="B9" ref-type="bibr">9</xref>]. Generally, there are three methods employed to reach this objective. The first one allows inhibiting the xanthine oxidase enzyme (allopurinol and febuxostat) and then blocking the production of uric acid and their precursor. The second one is intended to enhance uric acid excretion. The third strategy is based on the administration of recombinant uricases to convert uric acid to allantoin (<xref rid="tab1" ref-type="table">Table 1</xref>) [<xref rid="B9" ref-type="bibr">9</xref>, <xref rid="B20" ref-type="bibr">20</xref>].</p></sec><sec id="sec3"><title>3. Plants Used Traditionally to Treat Gout in Morocco</title><p>Medicinal plants have a prominent place in Moroccan phytotherapy as they contain several bioconstituents and antioxidants that are responsible for their beneficial effects. These plants and their compounds can be used as alternative or complementary medicines against gout pathology. <xref rid="tab2" ref-type="table"> Table 2</xref> classifies medicinal plants that are used traditionally in Morocco to manage gout disease.</p><p>
<xref ref-type="fig" rid="fig2">Figure 2</xref> shows the different families of the plants that had an antigout effect. In fact, the Lamiaceae family is the most dominant with six species, followed by Asteraceae with two herbs and the other families, which contain only one species for each one.</p></sec><sec id="sec4"><title>4. Discussion</title><p>Gout is a metabolic disease, characterized by burning, acute arthritis, and pain, which are the consequences of monosodium urate deposition into the joints [<xref rid="B49" ref-type="bibr">49</xref>, <xref rid="B50" ref-type="bibr">50</xref>].</p><p>The release of interleukin-1 <italic>&#x003b2;</italic> (IL-1 <italic>&#x003b2;</italic>), which is a cytokine, plays a key role in the initiation of the gout disease. Actually, the crystals lead to the activation of monocyte and then releasing caspase-1, which induces the IL-1 <italic>&#x003b2;</italic> secretion [<xref rid="B51" ref-type="bibr">51</xref>]. The blocking of this cytokine represents an effective treatment of acute and chronic gout. Among IL-1 <italic>&#x003b2;</italic> inhibitors that are used, there are anakinra, canakinumab, rilonacept, and pralnacasan [<xref rid="B52" ref-type="bibr">52</xref>&#x02013;<xref rid="B55" ref-type="bibr">55</xref>].</p><p>Diet plays also a role in the decrease of the uric acid level. In fact, beer, red meat, and sugar-sweetened beverages are responsible for the appearance of gout [<xref rid="B20" ref-type="bibr">20</xref>]. In the other hand, it was reported that some food consumption such as &#x0201c;cheery juice&#x0201d; (<italic>Prunus cerasus</italic>; Rosaceae), food that contains a high amount of vitamin C; coffee; and dairy products could maintain the uric acid's rate at normal values and then the management of gout [<xref rid="B56" ref-type="bibr">56</xref>, <xref rid="B57" ref-type="bibr">57</xref>].</p><p>Experimentally, there are several animal models of gout which are mainly monosodium urate crystal deposition-induced acute inflammation, potassium oxonate-induced hyperuricemia, and carrageenan-induced inflammation. In fact, uric acid is considered as a weak organic acid, and it is able to be ionized to monosodium urate crystal at pH&#x02009;=&#x02009;7.4 and at 37&#x000b0;C. Consequently, uric acid and urate crystals could deposit into the tissues, particularly joints and kidney, contributing to tissue damage [<xref rid="B8" ref-type="bibr">8</xref>]. The formation of monosodium urate crystals lead to the activation of macrophages that play a role in the secretion of inflammatory cytokines as IL-1 <italic>&#x003b2;</italic>. These mediators initiate with complement of (activated at crystals surfaces) a neutrophilic influx that is pathophysiologic feature of acute-gout. During the infiltration, crystals activate neutrophils, which contribute to the production of additional proinflammatory mediators such as arachidonic acid products (prostaglandine E2 and leukotriene B4). Monosodium urate crystals could persist into the joint fluid between attacks, which suggest that the inflammatory potential of monosodium urate crystals may be modulated by synovial fluid elements [<xref rid="B58" ref-type="bibr">58</xref>]. Potassium oxonate is a selective competitive inhibitor of uricase that play a key role in the conversion of uric acid to allantoin. Then, it induced hyperuricemia in rodents by blocking the effect of liver uricases [<xref rid="B59" ref-type="bibr">59</xref>]. Indeed, it was reported that potassium oxanate-induced hyperuricemic in rats developed a high level of renal proteins (URAT1 and GLUT9) and decreased the level of OTA1. However, the involved mechanisms are not clear yet [<xref rid="B60" ref-type="bibr">60</xref>]. The carrageenan-induced paw edema is another experiment model of gout that involves several inflammatory mediators such as TNF-<italic>&#x003b1;</italic> and IL-1 <italic>&#x003b2;</italic>. In fact, TNF-<italic>&#x003b1;</italic> triggers IL-1 <italic>&#x003b2;</italic> release and cytokine-induced neutrophil chemoattractant 1 which play a key role in the stimulation of the prostaglandins synthesis by cyclooxygenase-2. Furthermore, TNF-<italic>&#x003b1;</italic> activates iNOS responsible for NO synthesis, and then the responses of neutrophils increases to inflammatory stimuli [<xref rid="B61" ref-type="bibr">61</xref>].</p><p>Several agents are implicated in the treatment of gout disease as cyclooxygenase inhibitors, steroids, anti-inflammatory drugs, xanthine oxidase inhibitors, uricosuric, and uricases agents. Although these drugs are efficient, they are associated with various side effects such as digestives disorders, hepatotoxicity, renal dysfunction, hypersensitivity reaction, and skin allergy [<xref rid="B62" ref-type="bibr">62</xref>]. Actually, people search for alternatives that are characterized by their availability, fewer undesirable effects, and lower costs. These alternatives are based on medicinal plants.</p><p>In this review, we are citing some natural sources that are used traditionally in Morocco to treat gout disease. The table classifies 23 species, their scientific names, families, the traditionally used parts, traditional use method, experimental used part, extraction methods, and the experimental study towards gout, and we are reporting the toxic plants. In fact, the cited plants had shown experimentally an antigout effect by blocking and inhibiting &#x0201c;xanthine oxidase&#x0201d; which is the enzyme that catalyzes xanthine and hypoxanthine to uric acid. Xanthine oxidase inhibitors play an essential role to reduce uric acid levels, oxidative stress, and inflammation in the kidney and are able to prevent glomerular hypertension, afferent arteriolar, and ischemic renal histologic changes [<xref rid="B63" ref-type="bibr">63</xref>]. Besides, plants contain bioactive compounds that can enter into the active site of xanthine oxidase, producing a complex xanthine oxidase-bioactive compound through hydrophobic forces, related with surrounding xanthine oxidase amino acid and occupied the active site, thus preventing the entrance of substrate and inhibiting uric acid synthesis [<xref rid="B64" ref-type="bibr">64</xref>]. The histogram presented in this review shows the different families to which the studied plants belong. The Lamiaceae family is the most dominant family with six species. Recently, it was reported that the phenolic compounds isolated from the Lamiaceae herbs had anti-inflammatory and antioxidant actions [<xref rid="B65" ref-type="bibr">65</xref>, <xref rid="B66" ref-type="bibr">66</xref>]. Besides, species belonging to this family had shown a potent xanthine oxidase inhibition, and it was recommended to use them to prevent and treat gout disease [<xref rid="B67" ref-type="bibr">67</xref>].</p><p>
<italic>Capparis spinosa L.</italic> is the plant that has shown the highest inhibitory effect on xanthine oxidase activity than the other plants. The chloroform and ethyl acetate aerial part extract have shown a lower value of IC<sub>50</sub> (0.023 and 0.09&#x02009;mg/mL, respectively), followed by chloroform extract of root (0.32&#x02009;mg/mL), which means that these extracts are characterized by a potential activity on xanthine oxidase effect [<xref rid="B27" ref-type="bibr">27</xref>]. However, <italic>in vitro</italic> assay corresponds to <italic>in vitro</italic> enzymatic reactions of the enzyme xanthine oxidase. It allows to investigate directly the effect of plants on the xanthine oxidase inhibition activity. These studies do not require the use of a high number of animals in tests. However, it does not take into account the bioavailability of the principles active agents. Therefore, in vitro analysis is not enough and must confirmed by <italic>in vivo</italic> assays; using the different experimental animal models of gout.</p><p>Several phytochemical studies have reported the presence of alkaloids, terpenoids, saponins, phenolic compounds, carotenoids, and tocopherols in <italic>C. spinosa</italic> L. [<xref rid="B68" ref-type="bibr">68</xref>] that may act as xanthine oxidase inhibitors [<xref rid="B64" ref-type="bibr">64</xref>]. Fruits and leaves parts of this plant have shown the presence of phenolic and flavonoid compounds, particularly caffeic acid, catechin, chlorogenic acid, coumarin, ferulic acid, kaempferol, luteolin, quercetin, resveratrol, rutin, syringic acid, and vanillic acid which possesses an important xanthine oxidase inhibition [<xref rid="B64" ref-type="bibr">64</xref>, <xref rid="B69" ref-type="bibr">69</xref>&#x02013;<xref rid="B72" ref-type="bibr">72</xref>]. Furthermore, the roots are characterized by the presence of capparispine, cadabicine 26-O-<italic>&#x003b2;</italic>-D-glucoside, capparispine 26-O-<italic>&#x003b2;</italic>-D-glucoside, stachydrine, and 3-hydroxy-7-methoxy-2-methyl-4H-1,4-benzoxazine-4-carbaldehyde [<xref rid="B73" ref-type="bibr">73</xref>].</p><p>Colchicine is a natural drug that is isolated from <italic>Colchicum autumnale</italic> [<xref rid="B10" ref-type="bibr">10</xref>]. For almost 250 years, it was used as an anti-inflammatory agent [<xref rid="B74" ref-type="bibr">74</xref>]. Now, this alkaloid is used to manage gout disease, neurologic disability, familial Mediterranean fever, liver cirrhosis, amyloidosis, scleroderma, and Behcet's disease [<xref rid="B75" ref-type="bibr">75</xref>]. However, it can be toxic as it may cause gastrointestinal disorder and respiratory paralysis. For this reason, it is recommended to administer it according to therapeutic guidelines [<xref rid="B76" ref-type="bibr">76</xref>].</p><p>Gout has an important relationship with diabetes. Actually, the prevalence of gout in type 1 and 2 diabetes was, respectively, 1.9% and 10.12% [<xref rid="B77" ref-type="bibr">77</xref>]. Besides, many studies showed that people suffering from gout have a higher risk to develop type 2 diabetes [<xref rid="B78" ref-type="bibr">78</xref>]. Hyperuricaemia leads kidney failure, which is the consequence of crystal deposition in the renal tract. Moreover, type 2 diabetes can further aggravate this consequence [<xref rid="B79" ref-type="bibr">79</xref>].</p><p>Patients that had both gout and diabetes mellitus are more probable to have a higher mean of triglycerides, high-density lipoprotein cholesterol, renal dysfunction, lower hemoglobin, and peripheral-neuropathy. Besides, it was reported that these patients are more likely to be heavy, older, and men [<xref rid="B77" ref-type="bibr">77</xref>].</p></sec><sec id="sec5"><title>5. Conclusions</title><p>The present work showed that gout is treated with different methods used to block and inhibit uric acid secretion. The first strategy adopted by Moroccan people is based on medication uses which are associated with several adverse effects. However, the second method is more safe as it focused on the utilization of plants and their constituents that take an important place in Moroccan phytotherapy. In fact, this review classifies 23 species that have used traditionally in Morocco to treat gout and have shown experimentally significant xanthine oxidase inhibition: <italic>Ailanthus altissima, Artemisia herba-alba, Capparis spinosa</italic> L<italic>., Caryophyllus aromaticus</italic> L<italic>., Citrullus colocynthis</italic> L<italic>., Colchicum autumnale</italic> L<italic>., Ginkgo biloba</italic> L<italic>., Hyssopus officinalis</italic> L<italic>., Lavandula angustifolia, Melissa officinalis</italic> L<italic>., Mentha spicata</italic> L., <italic>Rosmarinus officinalis</italic> L<italic>., Smilax officinalis., Smilax medica Schltdl. and Cham., Smilax syphilitica, Smilax aristolochiifolia Mill., Smilax febrifuga Kunth., Smilax regelii Killip and C.V. Morton, Smilax aspera L., Solidago virgaurea</italic> L<italic>., Thymus vulgaris</italic> L<italic>., Urtica dioica</italic> L., and <italic>Zea mays</italic> L. However, several studies are needed to valorize these plants in order to use them to manage and maintain gout disease.</p></sec></body><back><sec sec-type="data-availability"><title>Data Availability</title><p>No data were used to support this study.</p></sec><sec sec-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare that there are no conflicts of interest.</p></sec><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>S. C. W.</given-names></name></person-group><article-title>Gout: a disease of kings</article-title><source><italic toggle="yes">Contributions to Nephrology</italic></source><year>2018</year><volume>192</volume><fpage>77</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1159/000484281</pub-id><pub-id pub-id-type="other">2-s2.0-85051925010</pub-id><pub-id pub-id-type="pmid">29393108</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Angalla</surname><given-names>R.</given-names></name><name><surname>Mounir</surname><given-names>A.</given-names></name><name><surname>Driouich</surname><given-names>S.</given-names></name><name><surname>Abourazzak</surname><given-names>F. Z.</given-names></name><name><surname>Harzy</surname><given-names>T.</given-names></name></person-group><article-title>Chronic tophaceous gout</article-title><source><italic toggle="yes">The Journal of Rheumatolog</italic></source><year>2016</year><volume>109</volume><issue>10</issue><fpage>681</fpage><lpage>682</lpage><pub-id pub-id-type="doi">10.1093/qjmed/hcw083</pub-id><pub-id pub-id-type="other">2-s2.0-84996799543</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>E. K.</given-names></name></person-group><article-title>Gout: a review of its aetiology and treatment</article-title><source><italic toggle="yes">Hong Kong Medical Journal=Xianggang Yi Xue Za Zhi</italic></source><year>2004</year><volume>10</volume><issue>4</issue><fpage>261</fpage><lpage>270</lpage><pub-id pub-id-type="pmid">15299172</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roddy</surname><given-names>E.</given-names></name><name><surname>Doherty</surname><given-names>M.</given-names></name></person-group><article-title>Epidemiology of gout</article-title><source><italic toggle="yes">Arthritis Research &#x00026; Therapy</italic></source><year>2010</year><volume>12</volume><issue>6</issue><fpage>p. 223</fpage><pub-id pub-id-type="doi">10.1186/ar3199</pub-id><pub-id pub-id-type="other">2-s2.0-79959265257</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krishnan</surname><given-names>E.</given-names></name><name><surname>Svendsen</surname><given-names>K.</given-names></name><name><surname>Neaton</surname><given-names>J. D.</given-names></name><name><surname>Grandits</surname><given-names>G.</given-names></name><name><surname>Kuller</surname><given-names>L. H.</given-names></name></person-group><article-title>Long-term cardiovascular mortality among middle-aged men with gout</article-title><source><italic toggle="yes">Archives of Internal Medicine</italic></source><year>2008</year><volume>168</volume><issue>10</issue><fpage>1104</fpage><lpage>1110</lpage><pub-id pub-id-type="doi">10.1001/archinte.168.10.1104</pub-id><pub-id pub-id-type="other">2-s2.0-44349151051</pub-id><pub-id pub-id-type="pmid">18504339</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>H. K.</given-names></name><name><surname>Atkinson</surname><given-names>K.</given-names></name><name><surname>Karlson</surname><given-names>E. W.</given-names></name><name><surname>Curhan</surname><given-names>G.</given-names></name></person-group><article-title>Obesity, weight change, hypertension, diuretic use, and risk of gout in men</article-title><source><italic toggle="yes">Archives of Internal Medicine</italic></source><year>2005</year><volume>165</volume><issue>7</issue><fpage>p. 742</fpage><pub-id pub-id-type="doi">10.1001/archinte.165.7.742</pub-id><pub-id pub-id-type="other">2-s2.0-17644371344</pub-id><pub-id pub-id-type="pmid">15824292</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grundy</surname><given-names>S. M.</given-names></name><name><surname>Brewer</surname><given-names>H. B.</given-names></name><name><surname>Cleeman</surname><given-names>J. I.</given-names></name><name><surname>Smith</surname><given-names>S. C.</given-names></name><name><surname>Lenfant</surname><given-names>C.</given-names></name></person-group><article-title>Definition of metabolic syndrome</article-title><source><italic toggle="yes">Circulation</italic></source><year>2004</year><volume>109</volume><issue>3</issue><fpage>433</fpage><lpage>438</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.0000111245.75752.C6</pub-id><pub-id pub-id-type="other">2-s2.0-0842277242</pub-id><pub-id pub-id-type="pmid">14744958</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Su</surname><given-names>H.-y.</given-names></name><name><surname>Yang</surname><given-names>C.</given-names></name><name><surname>Liang</surname><given-names>D.</given-names></name><name><surname>Liu</surname><given-names>H.-F.</given-names></name></person-group><article-title>Research advances in the mechanisms of hyperuricemia-induced renal injury</article-title><source><italic toggle="yes">BioMed Research International</italic></source><year>2020</year><volume>2020</volume><fpage>12</fpage><pub-id pub-id-type="publisher-id">5817348</pub-id><pub-id pub-id-type="doi">10.1155/2020/5817348</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Engel</surname><given-names>B.</given-names></name><name><surname>Just</surname><given-names>J.</given-names></name><name><surname>Bleckwenn</surname><given-names>M.</given-names></name><name><surname>Weckbecker</surname><given-names>K</given-names></name></person-group><article-title>Treatment options for gout</article-title><source><italic toggle="yes">Deutsches Arzteblatt International</italic></source><year>2017</year><volume>114</volume><issue>13</issue><fpage>215</fpage><lpage>222</lpage><pub-id pub-id-type="doi">10.3238/arztebl.2017.0215</pub-id><pub-id pub-id-type="other">2-s2.0-85017205067</pub-id><pub-id pub-id-type="pmid">28434436</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fern&#x000e1;ndez-Cuadros</surname><given-names>M. E.</given-names></name><name><surname>Goizueta-San-Martin</surname><given-names>G.</given-names></name><name><surname>Varas-de-Dios</surname><given-names>B.</given-names></name><etal/></person-group><article-title>Colchicine-induced rhabdomyolysis: clinical, biochemical, and neurophysiological features and Review of the Literature</article-title><source><italic toggle="yes">Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders</italic></source><year>2019</year><volume>12</volume><pub-id pub-id-type="doi">10.1177/1179544119849883</pub-id><pub-id pub-id-type="other">2-s2.0-85067631673</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Zhu</surname><given-names>J. X.</given-names></name><name><surname>Kong</surname><given-names>L. D.</given-names></name><name><surname>Yang</surname><given-names>C.</given-names></name><name><surname>Cheng</surname><given-names>C. H. K.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name></person-group><article-title>Administration of procyanidins from grape seeds reduces serum uric acid levels and decreases hepatic xanthine dehydrogenase/oxidase activities in oxonate-treated mice</article-title><source><italic toggle="yes">Basic &#x00026; Clinical Pharmacology &#x00026; Toxicology</italic></source><year>2004</year><volume>94</volume><issue>5</issue><fpage>232</fpage><lpage>237</lpage><pub-id pub-id-type="doi">10.1111/j.1742-7843.2004.pto940506.x</pub-id><pub-id pub-id-type="other">2-s2.0-2442647562</pub-id><pub-id pub-id-type="pmid">15125693</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eddouks</surname><given-names>M.</given-names></name><name><surname>Ajebli</surname><given-names>M.</given-names></name><name><surname>Hebi</surname><given-names>M.</given-names></name></person-group><article-title>Ethnopharmacological survey of medicinal plants used in Daraa-Tafilalet region (province of Errachidia), Morocco</article-title><source><italic toggle="yes">Journal of Ethnopharmacology</italic></source><year>2017</year><volume>198</volume><fpage>516</fpage><lpage>530</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2016.12.017</pub-id><pub-id pub-id-type="other">2-s2.0-85012893661</pub-id><pub-id pub-id-type="pmid">28003130</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Hmammouchi</surname><given-names>M.</given-names></name></person-group><source><italic toggle="yes">Les Plantes M&#x000e9;dicinales et Aromatiques Marocaines</italic></source><year>1999</year><publisher-loc>Rabat, Morocco</publisher-loc><publisher-name>de Fedala</publisher-name></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buchbinder</surname><given-names>R.</given-names></name><name><surname>Moi</surname><given-names>J. H. Y.</given-names></name><name><surname>Sriranganathan</surname><given-names>M. K.</given-names></name><name><surname>Edwards</surname><given-names>C. J.</given-names></name></person-group><article-title>Lifestyle interventions for chronic gout</article-title><source><italic toggle="yes">Cochrane Database of Systematic Reviews</italic></source><year>2013</year><volume>5</volume></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silverman</surname><given-names>W.</given-names></name><name><surname>Locovei</surname><given-names>S.</given-names></name><name><surname>Dahl</surname><given-names>G.</given-names></name></person-group><article-title>Probenecid, a gout remedy, inhibits pannexin 1 channels</article-title><source><italic toggle="yes">American Journal of Physiology-Cell Physiology</italic></source><year>2008</year><volume>295</volume><issue>3</issue><fpage>C761</fpage><lpage>C767</lpage><pub-id pub-id-type="doi">10.1152/ajpcell.00227.2008</pub-id><pub-id pub-id-type="other">2-s2.0-53449101616</pub-id><pub-id pub-id-type="pmid">18596212</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaufmann</surname><given-names>P.</given-names></name><name><surname>T&#x000f6;r&#x000f6;k</surname><given-names>M.</given-names></name><name><surname>H&#x000e4;nni</surname><given-names>A.</given-names></name><name><surname>Roberts</surname><given-names>P.</given-names></name><name><surname>Gasser</surname><given-names>R.</given-names></name><name><surname>Kr&#x000e4;henb&#x000fc;hl</surname><given-names>S.</given-names></name></person-group><article-title>Mechanisms of benzarone and benzbromarone-induced hepatic toxicity</article-title><source><italic toggle="yes">Hepatology</italic></source><year>2005</year><volume>41</volume><issue>4</issue><fpage>925</fpage><lpage>935</lpage><pub-id pub-id-type="pmid">15799034</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saag</surname><given-names>K. G.</given-names></name><name><surname>Fitz-Patrick</surname><given-names>D.</given-names></name><name><surname>Kopicko</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Lesinurad combined with allopurinol: a randomized, double blind, placebo controlled study in gout patients with an inadequate response to standard-of-care allopurinol (a US-based study)</article-title><source><italic toggle="yes">Arthritis &#x00026; Rheumatology</italic></source><year>2017</year><volume>69</volume><issue>1</issue><fpage>203</fpage><lpage>212</lpage><pub-id pub-id-type="doi">10.1002/art.39840</pub-id><pub-id pub-id-type="other">2-s2.0-85007281054</pub-id><pub-id pub-id-type="pmid">27564409</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>M.-H. H.</given-names></name><name><surname>Graham</surname><given-names>G. G.</given-names></name><name><surname>Williams</surname><given-names>K. M.</given-names></name><name><surname>Day</surname><given-names>R. O.</given-names></name></person-group><article-title>A benefit-risk assessment of benzbromarone in the treatment of gout</article-title><source><italic toggle="yes">Drug Safety</italic></source><year>2008</year><volume>31</volume><issue>8</issue><fpage>643</fpage><lpage>665</lpage><pub-id pub-id-type="doi">10.2165/00002018-200831080-00002</pub-id><pub-id pub-id-type="other">2-s2.0-47649130363</pub-id><pub-id pub-id-type="pmid">18636784</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herrington</surname><given-names>J. D.</given-names></name><name><surname>Dinh</surname><given-names>B. C.</given-names></name></person-group><article-title>Fixed, low-dose rasburicase for the treatment or prevention of hyperuricemia in adult oncology patients</article-title><source><italic toggle="yes">Journal of Oncology Pharmacy Practice</italic></source><year>2015</year><volume>21</volume><issue>2</issue><fpage>111</fpage><lpage>117</lpage><pub-id pub-id-type="doi">10.1177/1078155214520821</pub-id><pub-id pub-id-type="other">2-s2.0-84924961984</pub-id><pub-id pub-id-type="pmid">24549060</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dubchak</surname><given-names>N.</given-names></name><name><surname>Falasca</surname><given-names>G. F.</given-names></name></person-group><article-title>New and improved strategies for the treatment of gout</article-title><source><italic toggle="yes">International Journal of Nephrology and Renovascular Disease</italic></source><year>2010</year><volume>20</volume><issue>3</issue><fpage>145</fpage><lpage>166</lpage><pub-id pub-id-type="doi">10.2147/ijnrd.s6048</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El Harrad</surname><given-names>L.</given-names></name><name><surname>Amine</surname><given-names>A.</given-names></name></person-group><article-title>Amperometric biosensor based on prussian blue and nafion modified screen-printed electrode for screening of potential xanthine oxidase inhibitors from medicinal plants</article-title><source><italic toggle="yes">Enzyme and Microbial Technology</italic></source><year>2016</year><volume>85</volume><fpage>57</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1016/j.enzmictec.2016.01.006</pub-id><pub-id pub-id-type="other">2-s2.0-84955611404</pub-id><pub-id pub-id-type="pmid">26920482</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balkan</surname><given-names>B.</given-names></name><name><surname>Balkan</surname><given-names>S.</given-names></name><name><surname>Aydo&#x0011f;du</surname><given-names>H.</given-names></name><name><surname>&#x000d6;zcan</surname><given-names>O.</given-names></name></person-group><article-title>Antifungal activities of Ailanthus altissima swingle and juglans regia L. Leaves against some cereal fungi</article-title><source><italic toggle="yes">Journal of Applied Biological Sciences</italic></source><year>2014</year><volume>8</volume><issue>1</issue><fpage>76</fpage><lpage>79</lpage></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bourke</surname><given-names>C.</given-names></name></person-group><article-title>Lack of toxicity of Ailanthus altissima (tree-of-heaven) for goats.</article-title><source><italic toggle="yes">Australian Veterinary Journal</italic></source><year>1996</year><volume>74</volume><issue>6</issue><fpage>p. 465</fpage><pub-id pub-id-type="doi">10.1111/j.1751-0813.1996.tb07572.x</pub-id><pub-id pub-id-type="other">2-s2.0-0030339932</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ziyyat</surname><given-names>A.</given-names></name><name><surname>Legssyer</surname><given-names>A.</given-names></name><name><surname>Mekhfi</surname><given-names>H.</given-names></name><name><surname>Dassouli</surname><given-names>A.</given-names></name><name><surname>Serhrouchni</surname><given-names>M.</given-names></name><name><surname>Benjelloun</surname><given-names>W.</given-names></name></person-group><article-title>Phytotherapy of hypertension and diabetes in oriental Morocco</article-title><source><italic toggle="yes">Journal of Ethnopharmacology</italic></source><year>1997</year><volume>58</volume><issue>1</issue><fpage>45</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1016/S0378-8741(97)00077-9</pub-id><pub-id pub-id-type="other">2-s2.0-0030884460</pub-id><pub-id pub-id-type="pmid">9324004</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Khazraji</surname><given-names>S. M.</given-names></name><name><surname>Al-Shamaony</surname><given-names>L. A.</given-names></name><name><surname>Twaij</surname><given-names>H. A. A.</given-names></name></person-group><article-title>Hypoglycaemic effect of Artemisia herba alba. I. Effect of different parts and influence of the solvent on hypoglycaemic activity</article-title><source><italic toggle="yes">Journal of Ethnopharmacology</italic></source><year>1993</year><volume>40</volume><issue>3</issue><fpage>163</fpage><lpage>166</lpage><pub-id pub-id-type="doi">10.1016/0378-8741(93)90064-C</pub-id><pub-id pub-id-type="other">2-s2.0-0027716218</pub-id><pub-id pub-id-type="pmid">8145571</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Belakhdar</surname><given-names>J.</given-names></name></person-group><source><italic toggle="yes">Contribution &#x000e0; l&#x02019;&#x000e9;tude de la Pharmacop&#x000e9;e Traditionnelle au Maroc: La Situation Actuelle, les Produits, les Sources du Savoir Enqu&#x000ea;te Ethnopharmacologique de Terrain R&#x000e9;alis&#x000e9;e de 1969 &#x000f9; 1992</italic></source><year>1997</year><publisher-loc>Paris, France</publisher-loc><publisher-name>Metz</publisher-name></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baghiani</surname><given-names>A.</given-names></name><name><surname>Ameni</surname><given-names>D.</given-names></name><name><surname>Boumerfeg</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Studies of antioxidants and xanthine oxidase inhibitory potentials of root and aerial parts of medicinal plant Capparis spinosa L.</article-title><source><italic toggle="yes">American Journal of Medicine and Medical Sciences</italic></source><year>2012</year><volume>2</volume><issue>1</issue><fpage>25</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.5923/j.ajmms.20120201.06</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mollica</surname><given-names>A.</given-names></name><name><surname>Zengin</surname><given-names>G.</given-names></name><name><surname>Locatelli</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Anti-diabetic and anti-hyperlipidemic properties of Capparis spinosa L.: in vivo and in vitro evaluation of its nutraceutical potential</article-title><source><italic toggle="yes">Journal of Functional Foods</italic></source><year>2017</year><volume>35</volume><fpage>32</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1016/j.jff.2017.05.001</pub-id><pub-id pub-id-type="other">2-s2.0-85019859084</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chowdhury</surname><given-names>M. A. R.</given-names></name><name><surname>Manirujjama</surname></name><name><surname>Basak</surname><given-names>M.</given-names></name><name><surname>Rahman</surname><given-names>M. H.</given-names></name><name><surname>Sultana</surname><given-names>S.</given-names></name></person-group><article-title>Qualitative and quantitative screening of Syzygium aromaticum (Myrtaceae) and evaluation of anti-hyperglycemic effect</article-title><source><italic toggle="yes">International Journal of Pharmacognosy and Phytochemical Research</italic></source><year>2016</year><volume>8</volume><issue>7</issue><fpage>1209</fpage><lpage>1217</lpage></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nessa</surname><given-names>F.</given-names></name><name><surname>Khan</surname><given-names>A.</given-names></name><name><surname>Khan</surname><given-names>S.</given-names></name></person-group><article-title>Evaluation of antioxidant and xanthine oxidase inhibitory activity of different solvent extracts of leaves of <italic>Citrullus colocynthis</italic></article-title><source><italic toggle="yes">Pharmacognosy Research</italic></source><year>2014</year><volume>6</volume><issue>3</issue><fpage>p. 218</fpage><pub-id pub-id-type="doi">10.4103/0974-8490.132599</pub-id><pub-id pub-id-type="other">2-s2.0-84995443088</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bnouham</surname><given-names>M.</given-names></name><name><surname>Merhfour</surname><given-names>F. Z.</given-names></name><name><surname>Elachoui</surname><given-names>M.</given-names></name></person-group><article-title>Toxic effects of some medicinal plants used in Moroccan traditional medicine</article-title><source><italic toggle="yes">Moroccan Journal of Biology</italic></source><year>2006</year><volume>3</volume><fpage>21</fpage><lpage>30</lpage></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bnouham</surname><given-names>M.</given-names></name><name><surname>Ziyyat</surname><given-names>A.</given-names></name><name><surname>Mekhfi</surname><given-names>H.</given-names></name><name><surname>Tahri</surname><given-names>A.</given-names></name><name><surname>Legssyer</surname><given-names>A.</given-names></name></person-group><article-title>Medicinal plants with potential antidiabetic activity-a review of ten years of herbal medicine research (1990&#x02013;2000)</article-title><source><italic toggle="yes">International Journal of Diabetes and Metabolism</italic></source><year>2006</year><volume>14</volume><issue>1</issue><fpage>1</fpage><lpage>25</lpage></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hammadi</surname><given-names>D.</given-names></name><name><surname>Ahmed</surname><given-names>M.</given-names></name><name><surname>Boudjethia</surname><given-names>K. W.</given-names></name><name><surname>Boukhalfa</surname><given-names>A.</given-names></name><name><surname>Djebli</surname><given-names>N.</given-names></name></person-group><article-title>Ethnomedicinal survey of medicinal plants used in the western region of Algeria</article-title><source><italic toggle="yes">Medicinal &#x00026; Aromatic Plants</italic></source><year>2016</year><volume>5</volume><issue>1</issue><pub-id pub-id-type="doi">10.4172/2167-0412.1000221</pub-id></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naik</surname><given-names>S. R.</given-names></name><name><surname>Panda</surname><given-names>V. S.</given-names></name></person-group><article-title>Antioxidant and hepatoprotective effects of Ginkgo biloba phytosomes in carbon tetrachloride-induced liver injury in rodents</article-title><source><italic toggle="yes">Liver International</italic></source><year>2007</year><volume>27</volume><issue>3</issue><fpage>393</fpage><lpage>399</lpage><pub-id pub-id-type="doi">10.1111/j.1478-3231.2007.01463.x</pub-id><pub-id pub-id-type="other">2-s2.0-33947286256</pub-id><pub-id pub-id-type="pmid">17355462</pub-id></element-citation></ref><ref id="B35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fathiazad</surname><given-names>F.</given-names></name><name><surname>Hamedeyazdan</surname><given-names>S.</given-names></name></person-group><article-title>A review on Hyssopus officinalis L.: composition and biological activities,</article-title><source><italic toggle="yes">African Journal of Microbiology Research</italic></source><year>2011</year><volume>5</volume><issue>17</issue><fpage>1959</fpage><lpage>1966</lpage><pub-id pub-id-type="doi">10.5897/ajpp11.527</pub-id><pub-id pub-id-type="other">2-s2.0-81155135125</pub-id></element-citation></ref><ref id="B36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>K. N.</given-names></name></person-group><article-title>Traditional knowledge on ethnobotanical uses of plant biodiversity: a detailed study from the Indian western Himalaya</article-title><source><italic toggle="yes">Biodiversity: Research and Conservation</italic></source><year>2012</year><volume>28</volume><issue>1</issue><fpage>63</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.2478/v10119-012-0028-z</pub-id></element-citation></ref><ref id="B37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anad&#x000f3;n</surname><given-names>A.</given-names></name><name><surname>Mart&#x000ed;nez-larra&#x000f1;aga</surname><given-names>M. R.</given-names></name><name><surname>Mart&#x000ed;nez</surname><given-names>M. A.</given-names></name><etal/></person-group><article-title>Acute oral safety study of rosemary extracts in rats</article-title><source><italic toggle="yes">Journal of Food Protection</italic></source><year>2008</year><volume>71</volume><issue>4</issue><fpage>790</fpage><lpage>795</lpage><pub-id pub-id-type="doi">10.4315/0362-028x-71.4.790</pub-id><pub-id pub-id-type="other">2-s2.0-41849112714</pub-id><pub-id pub-id-type="pmid">18468034</pub-id></element-citation></ref><ref id="B38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Namjoo</surname><given-names>A.</given-names></name><name><surname>Mirvakili</surname><given-names>M.</given-names></name><name><surname>Shirzad</surname><given-names>H.</given-names></name><name><surname>Faghani</surname><given-names>M.</given-names></name></person-group><article-title>Biochemical, liver and renal toxicities of Melissa officinals hydroalcoholic extract on balb/C mice</article-title><source><italic toggle="yes">Journal of HerbMed Pharmacology</italic></source><year>2013</year><volume>2</volume><issue>2</issue><fpage>35</fpage><lpage>40</lpage></element-citation></ref><ref id="B39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ojewumi</surname><given-names>M.</given-names></name><name><surname>Adedokun</surname><given-names>S.</given-names></name><name><surname>Omodara</surname><given-names>O.</given-names></name><name><surname>Oyeniyi</surname><given-names>E.</given-names></name><name><surname>Taiwo</surname><given-names>O.</given-names></name><name><surname>Ojewumi</surname><given-names>E.</given-names></name></person-group><article-title>Phytochemical and antimicrobial activities of the leaf oil extract of Mentha spicata and its efficacy in repelling mosquito</article-title><source><italic toggle="yes">International Journal of Pharmaceutical Research &#x00026; Allied Sciences</italic></source><year>2017</year><volume>6</volume><issue>4</issue><fpage>17</fpage><lpage>27</lpage></element-citation></ref><ref id="B40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naidu</surname><given-names>J.</given-names></name><name><surname>Ismail</surname><given-names>R.</given-names></name><name><surname>Sasidharan</surname><given-names>S.</given-names></name></person-group><article-title>Acute oral toxicity and brine shrimp lethality of methanol extract of Mentha Spicata L (Lamiaceae)</article-title><source><italic toggle="yes">Tropical Journal of Pharmaceutical Research</italic></source><year>2014</year><volume>13</volume><issue>1</issue><fpage>101</fpage><lpage>107</lpage><pub-id pub-id-type="doi">10.4314/tjpr.v13i1.15</pub-id><pub-id pub-id-type="other">2-s2.0-84893379833</pub-id></element-citation></ref><ref id="B41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kong</surname><given-names>L. D.</given-names></name><name><surname>Cai</surname><given-names>Y.</given-names></name><name><surname>Huang</surname><given-names>W. W.</given-names></name><name><surname>Cheng</surname><given-names>C. H. K.</given-names></name><name><surname>Tan</surname><given-names>R. X.</given-names></name></person-group><article-title>Inhibition of xanthine oxidase by some Chinese medicinal plants used to treat gout</article-title><source><italic toggle="yes">Journal of Ethnopharmacology</italic></source><year>2000</year><volume>73</volume><issue>1-2</issue><fpage>199</fpage><lpage>207</lpage><pub-id pub-id-type="doi">10.1016/S0378-8741(00)00305-6</pub-id><pub-id pub-id-type="other">2-s2.0-0033806513</pub-id><pub-id pub-id-type="pmid">11025157</pub-id></element-citation></ref><ref id="B42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Intan Suziana</surname><given-names>Z.</given-names></name><name><surname>Nik Aina Syazana</surname><given-names>N. Z.</given-names></name><name><surname>Afzanizan</surname><given-names>A.</given-names></name><name><surname>Lau</surname><given-names>S. Y.</given-names></name><name><surname>Nurul Syahida</surname><given-names>R.</given-names></name><name><surname>Dasuki</surname><given-names>M. S.</given-names></name></person-group><article-title>Evaluation of toxicity in Smilax myosotiflora plant</article-title><source><italic toggle="yes">International Medical Journal</italic></source><year>2016</year><volume>23</volume><issue>6</issue><fpage>696</fpage><lpage>699</lpage></element-citation></ref><ref id="B43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thiem</surname><given-names>B.</given-names></name><name><surname>Goli&#x00144;ska</surname><given-names>O.</given-names></name></person-group><article-title>Antimicrobial activity of Solidago virgaurea L. from in vitro cultures</article-title><source><italic toggle="yes">Fitoterapia</italic></source><year>2002</year><volume>73</volume><issue>6</issue><fpage>514</fpage><lpage>516</lpage><pub-id pub-id-type="doi">10.1016/S0367-326X(02)00180-6</pub-id><pub-id pub-id-type="other">2-s2.0-0036802525</pub-id><pub-id pub-id-type="pmid">12385877</pub-id></element-citation></ref><ref id="B44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bucciarelli</surname><given-names>A.</given-names></name><name><surname>Minetti</surname><given-names>A.</given-names></name><name><surname>Milczakowskyg</surname><given-names>C.</given-names></name><name><surname>Skliar</surname><given-names>M.</given-names></name></person-group><article-title>Evaluation of gastroprotective activity and acute toxicity ofSolidago chilensisMeyen (Asteraceae)</article-title><source><italic toggle="yes">Pharmaceutical Biology</italic></source><year>2010</year><volume>48</volume><issue>9</issue><fpage>1025</fpage><lpage>1030</lpage><pub-id pub-id-type="doi">10.3109/13880200903453131</pub-id><pub-id pub-id-type="other">2-s2.0-77956014309</pub-id><pub-id pub-id-type="pmid">20731555</pub-id></element-citation></ref><ref id="B45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jamila</surname><given-names>F.</given-names></name><name><surname>Mostafa</surname><given-names>E.</given-names></name></person-group><article-title>Ethnobotanical survey of medicinal plants used by people in Oriental Morocco to manage various ailments</article-title><source><italic toggle="yes">Journal of Ethnopharmacology</italic></source><year>2014</year><volume>154</volume><issue>1</issue><fpage>76</fpage><lpage>87</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2014.03.016</pub-id><pub-id pub-id-type="other">2-s2.0-84900433826</pub-id><pub-id pub-id-type="pmid">24685583</pub-id></element-citation></ref><ref id="B46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benourad</surname><given-names>F.</given-names></name><name><surname>Kahvecioglu</surname><given-names>Z.</given-names></name><name><surname>Youcef-Benkada</surname><given-names>M.</given-names></name><name><surname>Colet</surname><given-names>J.-M.</given-names></name></person-group><article-title>Prospective evaluation of potential toxicity of repeated doses ofThymus vulgarisL. extracts in rats by means of clinical chemistry, histopathology and NMR-based metabonomic approach</article-title><source><italic toggle="yes">Drug Testing and Analysis</italic></source><year>2014</year><volume>6</volume><issue>10</issue><fpage>1069</fpage><lpage>1075</lpage><pub-id pub-id-type="doi">10.1002/dta.1606</pub-id><pub-id pub-id-type="other">2-s2.0-84916880691</pub-id><pub-id pub-id-type="pmid">24574060</pub-id></element-citation></ref><ref id="B47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dar</surname><given-names>S. A.</given-names></name><name><surname>Ganai</surname><given-names>F. A.</given-names></name><name><surname>Yousuf</surname><given-names>A. R.</given-names></name><name><surname>Balkhi</surname><given-names>M.</given-names></name><name><surname>Bhat</surname><given-names>T. M.</given-names></name><name><surname>Sharma</surname><given-names>P.</given-names></name></person-group><article-title>Pharmacological and toxicological evaluation ofUrtica dioica</article-title><source><italic toggle="yes">Pharmaceutical Biology</italic></source><year>2013</year><volume>51</volume><issue>2</issue><fpage>170</fpage><lpage>180</lpage><pub-id pub-id-type="doi">10.3109/13880209.2012.715172</pub-id><pub-id pub-id-type="other">2-s2.0-84872473890</pub-id><pub-id pub-id-type="pmid">23036051</pub-id></element-citation></ref><ref id="B48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ha</surname><given-names>A. W.</given-names></name><name><surname>Kang</surname><given-names>H. J.</given-names></name><name><surname>Kim</surname><given-names>S. L.</given-names></name><name><surname>Kim</surname><given-names>M. H.</given-names></name><name><surname>Kim</surname><given-names>W. K.</given-names></name></person-group><article-title>Acute and subacute toxicity evaluation of corn silk extract</article-title><source><italic toggle="yes">Preventive Nutrition and Food Science</italic></source><year>2018</year><volume>23</volume><issue>1</issue><fpage>70</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.3746/pnf.2018.23.1.70</pub-id><pub-id pub-id-type="other">2-s2.0-85045880514</pub-id><pub-id pub-id-type="pmid">29662850</pub-id></element-citation></ref><ref id="B49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brigham</surname><given-names>M. D.</given-names></name><name><surname>Radeck</surname><given-names>L. P.</given-names></name><name><surname>Mendonca</surname><given-names>C. M.</given-names></name><etal/></person-group><article-title>Gout severity in recipients of kidney transplant</article-title><source><italic toggle="yes">Transplantation Proceedings</italic></source><year>2019</year><volume>51</volume><issue>6</issue><fpage>1816</fpage><lpage>1821</lpage><pub-id pub-id-type="doi">10.1016/j.transproceed.2019.04.050</pub-id><pub-id pub-id-type="other">2-s2.0-85067886451</pub-id><pub-id pub-id-type="pmid">31256872</pub-id></element-citation></ref><ref id="B50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moilanen</surname><given-names>L. J.</given-names></name><name><surname>H&#x000e4;m&#x000e4;l&#x000e4;inen</surname><given-names>M.</given-names></name><name><surname>Lehtim&#x000e4;ki</surname><given-names>L.</given-names></name><name><surname>Nieminen</surname><given-names>R. M.</given-names></name><name><surname>Moilanen</surname><given-names>E.</given-names></name></person-group><article-title>Urate crystal induced inflammation and joint pain are reduced in transient receptor potential ankyrin 1 deficient mice - potential role for transient receptor potential ankyrin1 in gout</article-title><source><italic toggle="yes">PLoS One</italic></source><year>2015</year><volume>10</volume><issue>2</issue><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1371/journal.pone.0117770</pub-id><pub-id pub-id-type="other">2-s2.0-84922592759</pub-id></element-citation></ref><ref id="B51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dinarello</surname><given-names>C. A.</given-names></name></person-group><article-title>A clinical perspective of IL-1<italic>&#x003b2;</italic> as the gatekeeper of inflammation</article-title><source><italic toggle="yes">European Journal of Immunology</italic></source><year>2011</year><volume>41</volume><issue>5</issue><fpage>1203</fpage><lpage>1217</lpage><pub-id pub-id-type="doi">10.1002/eji.201141550</pub-id><pub-id pub-id-type="other">2-s2.0-79955148909</pub-id><pub-id pub-id-type="pmid">21523780</pub-id></element-citation></ref><ref id="B52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>D.</given-names></name><name><surname>Huston</surname><given-names>K. K.</given-names></name></person-group><article-title>IL-1 inhibition with anakinra in a patient with refractory gout</article-title><source><italic toggle="yes">JCR: Journal of Clinical Rheumatology</italic></source><year>2009</year><volume>15</volume><issue>7</issue><fpage>p. 366</fpage><pub-id pub-id-type="doi">10.1097/RHU.0b013e3181be2423</pub-id><pub-id pub-id-type="other">2-s2.0-70350168010</pub-id></element-citation></ref><ref id="B53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>So</surname><given-names>A.</given-names></name><name><surname>De Meulemeester</surname><given-names>M.</given-names></name><name><surname>Pikhlak</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Canakinumab for the treatment of acute flares in difficult-to-treat gouty arthritis: results of a multicenter, phase II, dose-ranging study</article-title><source><italic toggle="yes">Arthritis &#x00026; Rheumatism</italic></source><year>2010</year><volume>62</volume><issue>10</issue><fpage>3064</fpage><lpage>3076</lpage><pub-id pub-id-type="doi">10.1002/art.27600</pub-id><pub-id pub-id-type="other">2-s2.0-77957688721</pub-id><pub-id pub-id-type="pmid">20533546</pub-id></element-citation></ref><ref id="B54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Terkeltaub</surname><given-names>R. A.</given-names></name><name><surname>Schumacher</surname><given-names>H. R.</given-names></name><name><surname>Carter</surname><given-names>J. D.</given-names></name></person-group><article-title>Rilonacept in the treatment of acute gouty arthritis: a randomized, controlled clinical trial using indomethacin as the active comparator,</article-title><source><italic toggle="yes">Arthritis Research and Therapy</italic></source><year>2013</year><volume>15</volume><issue>1</issue><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1186/ar4159</pub-id><pub-id pub-id-type="other">2-s2.0-84873038233</pub-id></element-citation></ref><ref id="B55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Howley</surname><given-names>B.</given-names></name><name><surname>Fearnhead</surname><given-names>H. O.</given-names></name></person-group><article-title>Caspases as therapeutic targets</article-title><source><italic toggle="yes">Journal of Cellular and Molecular Medicine</italic></source><year>2008</year><volume>12</volume><issue>5</issue><fpage>1502</fpage><lpage>1516</lpage><pub-id pub-id-type="doi">10.1111/j.1582-4934.2008.00292.x</pub-id><pub-id pub-id-type="other">2-s2.0-54149107681</pub-id><pub-id pub-id-type="pmid">18298652</pub-id></element-citation></ref><ref id="B56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Howatson</surname><given-names>G.</given-names></name><name><surname>McHugh</surname><given-names>M. P.</given-names></name><name><surname>Hill</surname><given-names>J. A.</given-names></name><etal/></person-group><article-title>Influence of tart cherry juice on indices of recovery following marathon running</article-title><source><italic toggle="yes">Scandinavian Journal of Medicine &#x00026; Science in Sports</italic></source><year>2010</year><volume>20</volume><issue>6</issue><fpage>843</fpage><lpage>852</lpage><pub-id pub-id-type="doi">10.1111/j.1600-0838.2009.01005.x</pub-id><pub-id pub-id-type="other">2-s2.0-77958534123</pub-id><pub-id pub-id-type="pmid">19883392</pub-id></element-citation></ref><ref id="B57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>X.</given-names></name><name><surname>Curhan</surname><given-names>G.</given-names></name><name><surname>Forman</surname><given-names>J.</given-names></name><name><surname>Ascherio</surname><given-names>A.</given-names></name><name><surname>Choi</surname><given-names>H. K</given-names></name></person-group><article-title>Vitamin C intake and serum uric acid concentration in men</article-title><source><italic toggle="yes">The Journal of Rheumatology</italic></source><year>2008</year><volume>35</volume><issue>9</issue><fpage>1853</fpage><lpage>1858</lpage><pub-id pub-id-type="doi">10.1038/jid.2014.371</pub-id><pub-id pub-id-type="other">2-s2.0-84930151887</pub-id><pub-id pub-id-type="pmid">18464304</pub-id></element-citation></ref><ref id="B58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martillo</surname><given-names>M. A.</given-names></name><name><surname>Nazzal</surname><given-names>L.</given-names></name><name><surname>Crittenden</surname><given-names>D. B.</given-names></name></person-group><article-title>The crystallization of monosodium urate</article-title><source><italic toggle="yes">Current Rheumatology Reports</italic></source><year>2014</year><volume>16</volume><issue>2</issue><fpage>p. 400</fpage><pub-id pub-id-type="doi">10.1007/s11926-013-0400-9</pub-id><pub-id pub-id-type="other">2-s2.0-84896707900</pub-id></element-citation></ref><ref id="B59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>D.-H.</given-names></name><name><surname>Ye</surname><given-names>Y.-S.</given-names></name><name><surname>Wang</surname><given-names>C.-Y.</given-names></name><name><surname>Li</surname><given-names>Z.-L.</given-names></name><name><surname>Zheng</surname><given-names>H.</given-names></name><name><surname>Ma</surname><given-names>K.-L.</given-names></name></person-group><article-title>Potassium oxonate induces acute hyperuricemia in the tree shrew (tupaia belangeri chinensis)</article-title><source><italic toggle="yes">Experimental Animals</italic></source><year>2017</year><volume>66</volume><issue>3</issue><fpage>209</fpage><lpage>216</lpage><pub-id pub-id-type="doi">10.1538/expanim.16-0096</pub-id><pub-id pub-id-type="other">2-s2.0-85026868752</pub-id><pub-id pub-id-type="pmid">28302963</pub-id></element-citation></ref><ref id="B60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Su</surname><given-names>Q.</given-names></name><name><surname>Su</surname><given-names>H.</given-names></name><name><surname>Nong</surname><given-names>Z.</given-names></name><etal/></person-group><article-title>Hypouricemic and nephroprotective effects of an active fraction from</article-title><source><italic toggle="yes">KBR</italic></source><year>2018</year><volume>43</volume><issue>1</issue><fpage>220</fpage><lpage>233</lpage><pub-id pub-id-type="doi">10.1159/000487675</pub-id><pub-id pub-id-type="other">2-s2.0-85044739803</pub-id></element-citation></ref><ref id="B61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mansouri</surname><given-names>M. T.</given-names></name><name><surname>Hemmati</surname><given-names>A. A.</given-names></name><name><surname>Naghizadeh</surname><given-names>B.</given-names></name><name><surname>Mard</surname><given-names>S. A.</given-names></name><name><surname>Rezaie</surname><given-names>A.</given-names></name><name><surname>Ghorbanzadeh</surname><given-names>B.</given-names></name></person-group><article-title>A study of the mechanisms underlying the anti-inflammatory effect of ellagic acid in carrageenan-induced paw edema in rats,</article-title><source><italic toggle="yes">Indian Journal of Pharmacology</italic></source><year>2015</year><volume>47</volume><issue>3</issue><fpage>292</fpage><lpage>298</lpage><pub-id pub-id-type="doi">10.4103/0253-7613.157127</pub-id><pub-id pub-id-type="other">2-s2.0-84930342855</pub-id><pub-id pub-id-type="pmid">26069367</pub-id></element-citation></ref><ref id="B62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>M. T.</given-names></name><name><surname>Awale</surname><given-names>S.</given-names></name><name><surname>Tezuka</surname><given-names>Y.</given-names></name><name><surname>Le Tran</surname><given-names>Q.</given-names></name><name><surname>Watanabe</surname><given-names>H.</given-names></name><name><surname>Kadota</surname><given-names>S.</given-names></name></person-group><article-title>Xanthine oxidase inhibitory activity of Vietnamese medicinal plants</article-title><source><italic toggle="yes">Biological and Pharmaceutical Bulletin</italic></source><year>2004</year><volume>27</volume><issue>9</issue><fpage>1414</fpage><lpage>1421</lpage><pub-id pub-id-type="doi">10.1248/bpb.27.1414</pub-id><pub-id pub-id-type="other">2-s2.0-5644244025</pub-id><pub-id pub-id-type="pmid">15340229</pub-id></element-citation></ref><ref id="B63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pisano</surname><given-names>A.</given-names></name><name><surname>Cernaro</surname><given-names>V.</given-names></name><name><surname>Gembillo</surname><given-names>G.</given-names></name><name><surname>D&#x02019;Arrigo</surname><given-names>G.</given-names></name><name><surname>Buemi</surname><given-names>M.</given-names></name><name><surname>Bolignano</surname><given-names>D.</given-names></name></person-group><article-title>Xanthine oxidase inhibitors for improving renal function in chronic kidney disease patients: an updated systematic review and meta-analysis</article-title><source><italic toggle="yes">International Journal of Molecular Sciences</italic></source><year>2017</year><volume>18</volume><issue>11</issue><pub-id pub-id-type="doi">10.3390/ijms18112283</pub-id><pub-id pub-id-type="other">2-s2.0-85032739344</pub-id></element-citation></ref><ref id="B64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mehmood</surname><given-names>A.</given-names></name><name><surname>Ishaq</surname><given-names>M.</given-names></name><name><surname>Zhao</surname><given-names>L.</given-names></name><etal/></person-group><article-title>Natural compounds with xanthine oxidase inhibitory activity: a review</article-title><source><italic toggle="yes">Chemical Biology &#x00026; Drug Design</italic></source><year>2019</year><volume>93</volume><issue>4</issue><fpage>387</fpage><lpage>418</lpage><pub-id pub-id-type="doi">10.1111/cbdd.13437</pub-id><pub-id pub-id-type="other">2-s2.0-85060522238</pub-id><pub-id pub-id-type="pmid">30403440</pub-id></element-citation></ref><ref id="B65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peake</surname><given-names>P. W.</given-names></name><name><surname>Pussell</surname><given-names>B. A.</given-names></name><name><surname>Martyn</surname><given-names>P.</given-names></name><name><surname>Timmermans</surname><given-names>V.</given-names></name><name><surname>Charlesworth</surname><given-names>J. A.</given-names></name></person-group><article-title>The Inhibitory effect of rosmarinic acid on Complement involves the C5 convertase</article-title><source><italic toggle="yes">International Journal of Immunopharmacology</italic></source><year>1991</year><volume>13</volume><issue>7</issue><fpage>853</fpage><lpage>857</lpage><pub-id pub-id-type="doi">10.1016/0192-0561(91)90036-7</pub-id><pub-id pub-id-type="other">2-s2.0-0026012298</pub-id><pub-id pub-id-type="pmid">1761351</pub-id></element-citation></ref><ref id="B66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwon</surname><given-names>Y. I.</given-names></name><name><surname>Vattem</surname><given-names>D. A.</given-names></name><name><surname>Shetty</surname><given-names>K.</given-names></name></person-group><article-title>Evaluation of clonal herbs of Lamiaceae species for management of diabetes and hypertension</article-title><source><italic toggle="yes">Asia Pacific Journal of Clinical Nutrition</italic></source><year>2006</year><volume>15</volume><issue>1</issue><fpage>107</fpage><lpage>118</lpage><pub-id pub-id-type="pmid">16500886</pub-id></element-citation></ref><ref id="B67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonz&#x000e1;lez</surname><given-names>A. G.</given-names></name><name><surname>Bazzocchi</surname><given-names>I. L.</given-names></name><name><surname>Moujir</surname><given-names>L.</given-names></name><name><surname>Ravelo</surname><given-names>A. G.</given-names></name><name><surname>Correa</surname><given-names>M. D.</given-names></name><name><surname>Gupta</surname><given-names>M. P.</given-names></name></person-group><article-title>Xanthine oxidase inhibitory activity of some Panamanian plants from Celastraceae and Lamiaceae</article-title><source><italic toggle="yes">Journal of Ethnopharmacology</italic></source><year>1995</year><volume>46</volume><issue>1</issue><fpage>25</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1016/0378-8741(95)01225-3</pub-id><pub-id pub-id-type="other">2-s2.0-0028927226</pub-id><pub-id pub-id-type="pmid">7475120</pub-id></element-citation></ref><ref id="B68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vahid</surname><given-names>H.</given-names></name><name><surname>Rakhshandeh</surname><given-names>H.</given-names></name><name><surname>Ghorbani</surname><given-names>A.</given-names></name></person-group><article-title>Antidiabetic properties of Capparis spinosa L. and its components</article-title><source><italic toggle="yes">Biomedicine and Pharmacotherapy</italic></source><year>2017</year><volume>92</volume><fpage>293</fpage><lpage>302</lpage><pub-id pub-id-type="doi">10.1016/j.biopha.2017.05.082</pub-id><pub-id pub-id-type="other">2-s2.0-85019553932</pub-id><pub-id pub-id-type="pmid">28551550</pub-id></element-citation></ref><ref id="B69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nabavi</surname><given-names>S. F.</given-names></name><name><surname>Maggi</surname><given-names>F.</given-names></name><name><surname>Daglia</surname><given-names>M.</given-names></name><name><surname>Habtemariam</surname><given-names>S.</given-names></name><name><surname>Rastrelli</surname><given-names>L.</given-names></name><name><surname>Nabavi</surname><given-names>S. M.</given-names></name></person-group><article-title>Pharmacological effects of Capparis spinosa L.</article-title><source><italic toggle="yes">Phytotherapy Research</italic></source><year>2016</year><volume>30</volume><issue>11</issue><fpage>1733</fpage><lpage>1744</lpage><pub-id pub-id-type="doi">10.1002/ptr.5684</pub-id><pub-id pub-id-type="other">2-s2.0-84994051971</pub-id><pub-id pub-id-type="pmid">27406313</pub-id></element-citation></ref><ref id="B70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oudah</surname><given-names>S. K.</given-names></name><name><surname>Al-Salih</surname><given-names>R. M.</given-names></name><name><surname>Gusar</surname><given-names>S. H.</given-names></name></person-group><article-title>Study the role of polyphenolic extract of Capparis spinosa L. leaves as a hypoglycemic agent</article-title><source><italic toggle="yes">Journal of Scientific &#x00026; Engineering Research</italic></source><year>2004</year><volume>5</volume><issue>5</issue><fpage>1561</fpage><lpage>1575</lpage></element-citation></ref><ref id="B71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tlili</surname><given-names>A. K. N.</given-names></name><name><surname>Feriani</surname><given-names>A.</given-names></name><name><surname>Saadoui</surname><given-names>E.</given-names></name><name><surname>Nasri</surname><given-names>N.</given-names></name></person-group><article-title>Capparis spinosa leaves extract: source of bioantioxidants with nephroprotective and hepatoprotective effects</article-title><source><italic toggle="yes">Biomedicine &#x00026; Pharmacotherapy</italic></source><year>2017</year><volume>87</volume><fpage>171</fpage><lpage>179</lpage><pub-id pub-id-type="doi">10.1016/j.biopha.2016.12.052</pub-id><pub-id pub-id-type="other">2-s2.0-85007551384</pub-id><pub-id pub-id-type="pmid">28056421</pub-id></element-citation></ref><ref id="B72"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohebali</surname><given-names>M. H. S. N.</given-names></name><name><surname>Shahzadeh Fazeli</surname><given-names>S. A.</given-names></name><name><surname>Ghafoori</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Effect of flavonoids rich extract of Capparis spinosa on inflammatory involved genes in amyloid-beta peptide injected rat model of Alzheimer&#x02019;s disease</article-title><source><italic toggle="yes">Nutritional Neuroscience</italic></source><year>2016</year><volume>21</volume><issue>2</issue><fpage>143</fpage><lpage>150</lpage><pub-id pub-id-type="doi">10.1080/1028415x.2016.1238026</pub-id><pub-id pub-id-type="other">2-s2.0-84992371822</pub-id><pub-id pub-id-type="pmid">27778760</pub-id></element-citation></ref><ref id="B73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Ma</surname><given-names>Z. F.</given-names></name></person-group><article-title>Phytochemical and pharmacological properties of capparis spinosa as a medicinal plant</article-title><source><italic toggle="yes">Nutrients</italic></source><year>2018</year><volume>10</volume><issue>2</issue><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.3390/nu10020116</pub-id><pub-id pub-id-type="other">2-s2.0-85041030841</pub-id></element-citation></ref><ref id="B74"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prendergast</surname><given-names>B. D.</given-names></name><name><surname>George</surname><given-names>C. F.</given-names></name></person-group><article-title>Drug-induced rhabdomyolysis - mechanisms and management</article-title><source><italic toggle="yes">Postgraduate Medical Journal</italic></source><year>1993</year><volume>69</volume><issue>811</issue><fpage>333</fpage><lpage>336</lpage><pub-id pub-id-type="doi">10.1136/pgmj.69.811.333</pub-id><pub-id pub-id-type="other">2-s2.0-0027221788</pub-id><pub-id pub-id-type="pmid">8393995</pub-id></element-citation></ref><ref id="B75"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilbur</surname><given-names>K.</given-names></name><name><surname>Makowsky</surname><given-names>M.</given-names></name></person-group><article-title>Colchicine myotoxicity: case reports and literature review</article-title><source><italic toggle="yes">Pharmacotherapy</italic></source><year>2004</year><volume>24</volume><issue>12</issue><fpage>1784</fpage><lpage>1792</lpage><pub-id pub-id-type="doi">10.1592/phco.24.17.1784.52334</pub-id><pub-id pub-id-type="other">2-s2.0-9744279740</pub-id><pub-id pub-id-type="pmid">15585444</pub-id></element-citation></ref><ref id="B76"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Finkelstein</surname><given-names>Y.</given-names></name><name><surname>Aks</surname><given-names>S. E.</given-names></name><name><surname>Hutson</surname><given-names>J. R.</given-names></name></person-group><article-title>Colchicine poisoning: the dark side of an ancient drug,</article-title><source><italic toggle="yes">Clinical Toxicology</italic></source><year>2010</year><volume>48</volume><issue>5</issue><fpage>407</fpage><lpage>414</lpage><pub-id pub-id-type="doi">10.3109/15563650.2010.495348</pub-id><pub-id pub-id-type="other">2-s2.0-77954220989</pub-id><pub-id pub-id-type="pmid">20586571</pub-id></element-citation></ref><ref id="B77"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collier</surname><given-names>A.</given-names></name><name><surname>Stirling</surname><given-names>A.</given-names></name><name><surname>Cameron</surname><given-names>L.</given-names></name><name><surname>Hair</surname><given-names>M.</given-names></name><name><surname>Crosbie</surname><given-names>D.</given-names></name></person-group><article-title>Gout and diabetes: a common combination,</article-title><source><italic toggle="yes">Postgraduate Medical Journal</italic></source><year>2016</year><volume>92</volume><issue>1089</issue><fpage>372</fpage><lpage>378</lpage><pub-id pub-id-type="doi">10.1136/postgradmedj-2015-133691</pub-id><pub-id pub-id-type="other">2-s2.0-84973340088</pub-id><pub-id pub-id-type="pmid">27166424</pub-id></element-citation></ref><ref id="B78"><label>78</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>H. K.</given-names></name><name><surname>De Vera</surname><given-names>M. A.</given-names></name><name><surname>Krishnan</surname><given-names>E.</given-names></name></person-group><article-title>Gout and the risk of type 2 diabetes among men with a high cardiovascular risk profile</article-title><source><italic toggle="yes">Rheumatology</italic></source><year>2008</year><volume>47</volume><issue>10</issue><fpage>1567</fpage><lpage>1570</lpage><pub-id pub-id-type="doi">10.1093/rheumatology/ken305</pub-id><pub-id pub-id-type="other">2-s2.0-52949131004</pub-id><pub-id pub-id-type="pmid">18710901</pub-id></element-citation></ref><ref id="B79"><label>79</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ito</surname><given-names>H.</given-names></name><name><surname>Abe</surname><given-names>M.</given-names></name><name><surname>Mifune</surname><given-names>M.</given-names></name></person-group><article-title>Hyperuricemia is independently associated with coronary heart disease and renal dysfunction in patients with type 2 diabetes mellitus</article-title><source><italic toggle="yes">PLoS One</italic></source><year>2011</year><volume>6</volume><issue>11</issue><pub-id pub-id-type="doi">10.1371/journal.pone.0027817</pub-id><pub-id pub-id-type="other">2-s2.0-84859220204</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="fig1" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Mechanisms underlying hyperuricemia.</p></caption><graphic xlink:href="SCIENTIFICA2020-8637583.001"/></fig><fig id="fig2" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Repartition of the different antigout plant families.</p></caption><graphic xlink:href="SCIENTIFICA2020-8637583.002"/></fig><table-wrap id="tab1" orientation="portrait" position="float"><label>Table 1</label><caption><p>The gout treatment drugs and their side effects.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Gout treatment options</th><th align="center" rowspan="1" colspan="1">Drugs</th><th align="center" rowspan="1" colspan="1">Effect</th><th align="center" rowspan="1" colspan="1">Doses (mg/day)</th><th align="center" rowspan="1" colspan="1">Side effects</th></tr></thead><tbody><tr><td align="left" rowspan="8" colspan="1">Xanthine oxidase inhibitors</td><td align="center" rowspan="4" colspan="1">Allopurinol</td><td align="center" rowspan="4" colspan="1">Reduces the level of blood uric acid [<xref rid="B9" ref-type="bibr">9</xref>]</td><td align="center" rowspan="4" colspan="1">50&#x02013;800 [<xref rid="B9" ref-type="bibr">9</xref>]</td><td align="center" rowspan="1" colspan="1">(i) Digestive disorders</td></tr><tr><td align="center" rowspan="1" colspan="1">(ii) Hypersensitivity syndrome</td></tr><tr><td align="center" rowspan="1" colspan="1">(iii) Hepatotoxicity</td></tr><tr><td align="center" rowspan="1" colspan="1">(iv) Skin reactions [<xref rid="B14" ref-type="bibr">14</xref>]</td></tr><tr><td align="center" rowspan="4" colspan="1">Febuxostat</td><td align="center" rowspan="4" colspan="1">Reduces the level of blood uric acid [<xref rid="B9" ref-type="bibr">9</xref>]</td><td align="center" rowspan="4" colspan="1">80&#x02013;120 [<xref rid="B9" ref-type="bibr">9</xref>]</td><td align="center" rowspan="1" colspan="1">(i) Digestive disorders</td></tr><tr><td align="center" rowspan="1" colspan="1">(ii) Headache</td></tr><tr><td align="center" rowspan="1" colspan="1">(iii) Liver problems</td></tr><tr><td align="center" rowspan="1" colspan="1">(iv) Rash in the skin [<xref rid="B9" ref-type="bibr">9</xref>]</td></tr><tr><td align="left" colspan="5" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="8" colspan="1">Uricosuric agents</td><td align="center" rowspan="3" colspan="1">Probenecid</td><td align="center" rowspan="3" colspan="1">Inhibition of the uric acid reabsorption [<xref rid="B15" ref-type="bibr">15</xref>]</td><td align="center" rowspan="3" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">(i) Gastrointestinal tract irritation</td></tr><tr><td align="center" rowspan="1" colspan="1">(ii) Anorexia</td></tr><tr><td align="center" rowspan="1" colspan="1">(iii) Skin reactions [<xref rid="B9" ref-type="bibr">9</xref>]</td></tr><tr><td align="center" rowspan="1" colspan="1">Benzbromarone</td><td align="left" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">100</td><td align="center" rowspan="1" colspan="1">(i) Hepatotoxicity [<xref rid="B16" ref-type="bibr">16</xref>]</td></tr><tr><td align="center" rowspan="3" colspan="1">Lesinurad</td><td align="center" rowspan="3" colspan="1">Inhibition of the uric acid reabsorption [<xref rid="B17" ref-type="bibr">17</xref>]</td><td align="left" rowspan="3" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">(i) Gastroesophageal reflux disease</td></tr><tr><td align="center" rowspan="1" colspan="1">(ii) Headache</td></tr><tr><td align="center" rowspan="1" colspan="1">(iii) Influenza associated with kidney failure [<xref rid="B9" ref-type="bibr">9</xref>]</td></tr><tr><td align="center" rowspan="1" colspan="1">Losartan/fenofibrate</td><td align="center" rowspan="1" colspan="1">Lowering urate formation [<xref rid="B18" ref-type="bibr">18</xref>]</td><td align="left" rowspan="1" colspan="1">&#x02009;</td><td align="left" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="left" colspan="5" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="3" colspan="1">Uricases</td><td align="center" rowspan="3" colspan="1">Rasburicase</td><td align="center" rowspan="3" colspan="1">The recombinant form of uricases</td><td align="left" rowspan="3" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">(i) Infusion problems [<xref rid="B9" ref-type="bibr">9</xref>]</td></tr><tr><td align="center" rowspan="1" colspan="1">(ii) Antibody formation [<xref rid="B19" ref-type="bibr">19</xref>]</td></tr><tr><td align="center" rowspan="1" colspan="1">(iii) Anaphylaxis [<xref rid="B9" ref-type="bibr">9</xref>]</td></tr></tbody></table></table-wrap><table-wrap id="tab2" orientation="portrait" position="float"><label>Table 2</label><caption><p>List of plants used in Moroccan alternative medicine as antigout.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Scientific name</th><th align="center" rowspan="1" colspan="1">Family</th><th align="center" rowspan="1" colspan="1">Traditional used part</th><th align="center" rowspan="1" colspan="1">Traditional method of use</th><th align="center" rowspan="1" colspan="1">Experimentalused part</th><th align="center" rowspan="1" colspan="1">Extraction methods</th><th align="center" rowspan="1" colspan="1">Experimental study</th><th align="center" rowspan="1" colspan="1">Results</th><th align="center" rowspan="1" colspan="1">Toxicity</th><th align="center" rowspan="1" colspan="1">Ref.</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">
<italic>Ailanthus altissima</italic>
</td><td align="center" rowspan="1" colspan="1">Simaroubaceae</td><td align="center" rowspan="1" colspan="1">Flowers</td><td align="center" rowspan="1" colspan="1">Infusion</td><td align="center" rowspan="1" colspan="1">Flowers</td><td align="center" rowspan="1" colspan="1">Decoction (distilled water)</td><td align="center" rowspan="1" colspan="1">
<italic>In vitro</italic> (0.1, 0.5, 1.0, and 2.0&#x02009;mg/mL)</td><td align="center" rowspan="1" colspan="1">Inhibition of xanthine oxidase</td><td align="center" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">[<xref rid="B21" ref-type="bibr">21</xref>&#x02013;<xref rid="B23" ref-type="bibr">23</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>Artemisia herba-alba</italic>
</td><td align="center" rowspan="1" colspan="1">Asteraceae</td><td align="center" rowspan="1" colspan="1">Flowers</td><td align="center" rowspan="1" colspan="1">Infusion</td><td align="center" rowspan="1" colspan="1">Flowers</td><td align="center" rowspan="1" colspan="1">Decoction (distilled water)</td><td align="center" rowspan="1" colspan="1">
<italic>In vitro</italic> (0.1, 0.5, 1.0, and 2.0&#x02009;mg/mL)</td><td align="center" rowspan="1" colspan="1">Inhibition of xanthine oxidase</td><td align="center" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">[<xref rid="B21" ref-type="bibr">21</xref>, <xref rid="B24" ref-type="bibr">24</xref>, <xref rid="B25" ref-type="bibr">25</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>Capparis spinosa L.</italic>
</td><td align="center" rowspan="1" colspan="1">Caparidaceae</td><td align="center" rowspan="1" colspan="1">Fruit</td><td align="center" rowspan="1" colspan="1">Mixed the dried fruit with honey</td><td align="center" rowspan="1" colspan="1">Root and aerial part</td><td align="center" rowspan="1" colspan="1">Maceration (distilled water, methanol, hexane, chloroform, and ethyl acetate)</td><td align="center" rowspan="1" colspan="1">
<italic>In vitro</italic>
</td><td align="center" rowspan="1" colspan="1">Inhibition of xanthine oxidase (crude extract of root, IC<sub>50,</sub> 0.32, 0.36, and 4.32&#x02009;mg/mL) (crude extract of aerial part, IC<sub>50,</sub> 0.023, 0.09, and 1.35&#x02009;mg/mL)</td><td align="center" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">[<xref rid="B26" ref-type="bibr">26</xref>&#x02013;<xref rid="B28" ref-type="bibr">28</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>Caryophyllus aromaticus L.</italic>
</td><td align="center" rowspan="1" colspan="1">Myrtaceae</td><td align="center" rowspan="1" colspan="1">Flowers</td><td align="center" rowspan="1" colspan="1">Infusion</td><td align="center" rowspan="1" colspan="1">Flowers</td><td align="center" rowspan="1" colspan="1">Decoction (distilled water)</td><td align="center" rowspan="1" colspan="1">
<italic>In vitro</italic> (0.1, 0.5, 1.0, and 2.0&#x02009;mg/mL)</td><td align="center" rowspan="1" colspan="1">Inhibition of xanthine oxidase</td><td align="center" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">[<xref rid="B21" ref-type="bibr">21</xref>, <xref rid="B24" ref-type="bibr">24</xref>, <xref rid="B29" ref-type="bibr">29</xref>]</td></tr><tr><td align="left" rowspan="4" colspan="1">
<italic>Citrullus colocynthis L.</italic>
</td><td rowspan="4" align="center" colspan="1">Cucurbitaceae</td><td rowspan="4" align="center" colspan="1">Pulp</td><td rowspan="4" align="center" colspan="1">Decoction (water and honey) and maceration</td><td rowspan="4" align="center" colspan="1">Leaves</td><td rowspan="4" align="center" colspan="1">Soxhlet extraction (hexane, chloroform, and methanol)</td><td rowspan="4" align="center" colspan="1">
<italic>In vitro</italic>
</td><td rowspan="4" align="center" colspan="1">Inhibition of xanthine oxidase<break/>IC<sub>50</sub>&#x02009;=&#x02009;0.58<break/>IC<sub>50</sub>&#x02009;=&#x02009;1.8<break/>IC<sub>50</sub>&#x02009;=&#x02009;5.96</td><td rowspan="4" align="center" colspan="1">Toxic<break/>LD<sub>50</sub>&#x02009;=&#x02009;2500&#x02009;mg/kg</td><td align="center" rowspan="1" colspan="1">[<xref rid="B26" ref-type="bibr">26</xref>, <xref rid="B30" ref-type="bibr">30</xref>, <xref rid="B31" ref-type="bibr">31</xref>]</td></tr><tr><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>Colchicum autumnale L.</italic>
</td><td align="center" rowspan="1" colspan="1">Liliaceae</td><td align="center" rowspan="1" colspan="1">Seeds and capsule</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">Antigout action</td><td align="center" rowspan="1" colspan="1">Toxic</td><td align="center" rowspan="1" colspan="1">[<xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B31" ref-type="bibr">31</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>Ginkgo biloba L.</italic>
</td><td align="center" rowspan="1" colspan="1">Ginkgoaceae</td><td align="center" rowspan="1" colspan="1">Leaves</td><td align="center" rowspan="1" colspan="1">Infusion</td><td align="center" rowspan="1" colspan="1">Leaves</td><td align="center" rowspan="1" colspan="1">Decoction</td><td align="center" rowspan="1" colspan="1">
<italic>In vitro</italic> (0.1, 0.5, 1.0, and 2.0&#x02009;mg/mL)</td><td align="center" rowspan="1" colspan="1">Inhibition of xanthine oxidase</td><td align="center" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">[<xref rid="B21" ref-type="bibr">21</xref>, <xref rid="B32" ref-type="bibr">32</xref>&#x02013;<xref rid="B34" ref-type="bibr">34</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>Hyssopus officinalis L.</italic>
</td><td align="center" rowspan="1" colspan="1">Lamiaceae</td><td align="center" rowspan="1" colspan="1">Flowers</td><td align="center" rowspan="1" colspan="1">Infusion</td><td align="center" rowspan="1" colspan="1">Flowers</td><td align="center" rowspan="1" colspan="1">Decoction</td><td align="center" rowspan="1" colspan="1">
<italic>In vitro</italic> (0.1, 0.5, 1.0, and 2.0&#x02009;mg/mL)</td><td align="center" rowspan="1" colspan="1">Inhibition of xanthine oxidase</td><td align="center" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">[<xref rid="B21" ref-type="bibr">21</xref>, <xref rid="B35" ref-type="bibr">35</xref>&#x02013;<xref rid="B37" ref-type="bibr">37</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>Lavandula angustifolia</italic>
</td><td align="center" rowspan="1" colspan="1">Lamiaceae</td><td align="center" rowspan="1" colspan="1">Flowers</td><td align="center" rowspan="1" colspan="1">Infusion</td><td align="center" rowspan="1" colspan="1">Flowers</td><td align="center" rowspan="1" colspan="1">Decoction</td><td align="center" rowspan="1" colspan="1">
<italic>In vitro</italic> (0.1, 0.5, 1.0, and 2.0&#x02009;mg/mL)</td><td align="center" rowspan="1" colspan="1">Inhibition of xanthine oxidase</td><td align="center" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">[<xref rid="B21" ref-type="bibr">21</xref>, <xref rid="B26" ref-type="bibr">26</xref>, <xref rid="B37" ref-type="bibr">37</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>Melissa officinalis L.</italic>
</td><td align="center" rowspan="1" colspan="1">Lamiaceae</td><td align="center" rowspan="1" colspan="1">Leaves</td><td align="center" rowspan="1" colspan="1">Infusion</td><td align="center" rowspan="1" colspan="1">Leaves</td><td align="center" rowspan="1" colspan="1">Decoction</td><td align="center" rowspan="1" colspan="1">
<italic>In vitro</italic> (0.1, 0.5, 1.0, and 2.0&#x02009;mg/mL)</td><td align="center" rowspan="1" colspan="1">Inhibition of xanthine oxidase</td><td align="center" rowspan="1" colspan="1">Hepatotoxic</td><td align="center" rowspan="1" colspan="1">[<xref rid="B21" ref-type="bibr">21</xref>, <xref rid="B26" ref-type="bibr">26</xref>, <xref rid="B38" ref-type="bibr">38</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>Mentha spicata L.</italic>
</td><td align="center" rowspan="1" colspan="1">Lamiaceae</td><td align="center" rowspan="1" colspan="1">Leaves</td><td align="center" rowspan="1" colspan="1">Infusion</td><td align="center" rowspan="1" colspan="1">Leaves</td><td align="center" rowspan="1" colspan="1">Decoction</td><td align="center" rowspan="1" colspan="1">
<italic>In vitro</italic> (0.1, 0.5, 1.0, and 2.0&#x02009;mg/mL)</td><td align="center" rowspan="1" colspan="1">Inhibition of xanthine oxidase</td><td align="center" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">[<xref rid="B21" ref-type="bibr">21</xref>, <xref rid="B39" ref-type="bibr">39</xref>, <xref rid="B40" ref-type="bibr">40</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>Rosmarinus officinalis L.</italic>
</td><td align="center" rowspan="1" colspan="1">Lamiaceae</td><td align="center" rowspan="1" colspan="1">Leaves</td><td align="center" rowspan="1" colspan="1">Infusion</td><td align="center" rowspan="1" colspan="1">Leaves</td><td align="center" rowspan="1" colspan="1">Decoction</td><td align="center" rowspan="1" colspan="1">
<italic>In vitro</italic> (0.1, 0.5, 1.0, and 2.0&#x02009;mg/mL)</td><td align="center" rowspan="1" colspan="1">Inhibition of xanthine oxidase</td><td align="center" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">[<xref rid="B21" ref-type="bibr">21</xref>, <xref rid="B24" ref-type="bibr">24</xref>, <xref rid="B37" ref-type="bibr">37</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>Smilax officinalis</italic>
<break/>
<italic>Smilax medica</italic>
<break/>
<italic>Smilax syphilitica</italic>
<break/>
<italic>Smilax aristolochiifolia Mill</italic>
<break/>
<italic>Smilax febrifuga Kunth.</italic>
<break/>
<italic>Smilax regelii Killip</italic> and <italic>C.V. Morton Smilax aspera L.</italic></td><td align="center" rowspan="1" colspan="1">Similaceae</td><td align="center" rowspan="1" colspan="1">Root</td><td align="center" rowspan="1" colspan="1">Cooking the herb with the meat.</td><td align="center" rowspan="1" colspan="1">Rhizome</td><td align="center" rowspan="1" colspan="1">Maceration</td><td align="center" rowspan="1" colspan="1">
<italic>In vitro</italic>
</td><td align="center" rowspan="1" colspan="1">Inhibition of xanthine oxidase<break/>IC<sub>50</sub>&#x02009;=&#x02009;33% (methanol extract)<break/>IC<sub>50</sub>&#x02009;=&#x02009;96% (water extract)</td><td align="center" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">[<xref rid="B26" ref-type="bibr">26</xref>, <xref rid="B41" ref-type="bibr">41</xref>, <xref rid="B42" ref-type="bibr">42</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>Solidago virgaurea L.</italic>
</td><td align="center" rowspan="1" colspan="1">Asteraceae</td><td align="center" rowspan="1" colspan="1">Leaves</td><td align="center" rowspan="1" colspan="1">Infusion</td><td align="center" rowspan="1" colspan="1">Leaves</td><td align="center" rowspan="1" colspan="1">Decoction</td><td align="center" rowspan="1" colspan="1">
<italic>In vitro</italic> (0.1, 0.5, 1.0, and 2.0&#x02009;mg/mL)</td><td align="center" rowspan="1" colspan="1">Inhibition of xanthine oxidase</td><td align="center" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">[<xref rid="B21" ref-type="bibr">21</xref>, <xref rid="B43" ref-type="bibr">43</xref>, <xref rid="B44" ref-type="bibr">44</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>Thymus vulgaris L</italic>
</td><td align="center" rowspan="1" colspan="1">Lamiaceae</td><td align="center" rowspan="1" colspan="1">Leaves</td><td align="center" rowspan="1" colspan="1">Infusion</td><td align="center" rowspan="1" colspan="1">Leaves</td><td align="center" rowspan="1" colspan="1">Decoction</td><td align="center" rowspan="1" colspan="1">
<italic>In vitro</italic> (0.1, 0.5, 1.0, and 2.0&#x02009;mg/mL)</td><td align="center" rowspan="1" colspan="1">Inhibition of xanthine oxidase</td><td align="center" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">[<xref rid="B21" ref-type="bibr">21</xref>, <xref rid="B45" ref-type="bibr">45</xref>, <xref rid="B46" ref-type="bibr">46</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>Urtica dioica L.</italic>
</td><td align="center" rowspan="1" colspan="1">Urticaceae</td><td align="center" rowspan="1" colspan="1">Leaves</td><td align="center" rowspan="1" colspan="1">Infusion</td><td align="center" rowspan="1" colspan="1">Leaves</td><td align="center" rowspan="1" colspan="1">Decoction</td><td align="center" rowspan="1" colspan="1">
<italic>In vitro</italic> (0.1, 0.5, 1.0, and 2.0&#x02009;mg/mL)</td><td align="center" rowspan="1" colspan="1">Inhibition of xanthine oxidase</td><td align="center" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">[<xref rid="B21" ref-type="bibr">21</xref>, <xref rid="B24" ref-type="bibr">24</xref>, <xref rid="B47" ref-type="bibr">47</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>Zea mays L.</italic>
</td><td align="center" rowspan="1" colspan="1">Poaceae</td><td align="center" rowspan="1" colspan="1">Stigma</td><td align="center" rowspan="1" colspan="1">Infusion</td><td align="center" rowspan="1" colspan="1">Stigma</td><td align="center" rowspan="1" colspan="1">Decoction</td><td align="center" rowspan="1" colspan="1">
<italic>In vitro</italic> (0.1, 0.5, 1.0, and 2.0&#x02009;mg/mL)</td><td align="center" rowspan="1" colspan="1">Inhibition of xanthine oxidase</td><td align="center" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">[<xref rid="B21" ref-type="bibr">21</xref>, <xref rid="B45" ref-type="bibr">45</xref>, <xref rid="B48" ref-type="bibr">48</xref>]</td></tr></tbody></table></table-wrap></floats-group></article>